Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

Insulin injection practices are a critical aspect of diabetes management, particularly for individuals with type 1 and type 2 diabetes. Proper injection techniques and site rotation are essential ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

A medical expert, who testified Tuesday in the murder trial of Natalie Cochran, stated that for a blood glucose level to register at 21 in a healthy, nondiabetic male with no other conditions, the ...

A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...

New Delhi: Sun Pharma Labs has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug ...

The announcement that inhaled insulin will soon be available in India has understandably generated a lot of excitement and ...

By understanding the disease and the treatment options, pet owners can ensure their dogs and cats have healthy and happy ...

AstraZeneca announced that the EC green-lighted the new formulation of the once-weekly type-2 diabetes injection, which will be marketed as Bydureon BCise (exenatide 2mg prolonged-release suspension).